July 10, 2020 A photo shows vaccines in prefilled, single-use
syringes before the inspection and packaging phase at the French
pharmaceutical company Sanofi’s world distribution centre in Val de
Reuil, France. JOEL SAGET / AFP
The EU announced Friday that it had struck a deal with
French pharmaceutical giant Sanofi for 300 million doses of a
potential coronavirus vaccine.
The European Commission, the bloc’s executive arm which
negotiated the agreement, said it would allow all 27 member
countries to purchase the vaccine once it was proven to be safe and
effective.
The announcement comes on the same day the US government said it
would provide up to $2.1 billion to Sanofi and GSK for the
development of a COVID-19 vaccine, as the world continues to battle
the pandemic.
As official data revealed coronavirus lockdowns had caused a
devastating 12 percent economic contraction in the EU in the second
quarter of 2020, European Commission President Ursula von der Leyen
said the bloc was doing everything it could to help find a
vaccine.
“We are in advanced discussions with several other companies,”
she said in a statement, adding that Europe was investing in a
“diversified portfolio of promising vaccines”.
“This increases our chances to obtain rapidly an effective
remedy against the virus.”
(adsbygoogle = window.adsbygoogle || []).push({});
July 29, 2013, the headquarters of the British pharmaceutical
company GlaxoSmithKline (GSK) is pictured in west London. Ben
STANSALL / AFP
Sanofi hopes to seek marketing authorisation from the European
Medicines Agency for a vaccine in June next year.
The French government welcomed Friday’s announcement as a
“decisive step”.
“This future contract will allow each EU member state to order
the vaccine under good conditions once it has shown enough proof of
its effectiveness and safety,” the French government said in a
statement.
Six months after the World Health Organization (WHO) declared a
global emergency, the novel coronavirus has infected more than 17
million people, with global daily cases now approaching the 300,000
mark.
Europe overall has nearly 210,000 deaths from 3.2 million cases,
and with infections rising again in several countries there are
fears a “second wave” of the pandemic could be on the way.
The highly restrictive lockdowns enforced to deal with the
pandemic earlier this year has caused economic turmoil and an
effective vaccine may be the only long-term solution to the highly
contagious respiratory disease.
AFP
Read more https://swordpress.com.ng/2020/08/01/eu-reserves-300mn-doses-of-potential-covid-19-vaccine/